Review of "All Eyes on Gilead" article in Bloomberg

I’ve been doing some research on Remdesivir and Cyanide. It began after a friend sent me a link to the Stew Peters show on Rumble where he interviewed Thomas Baine on his Remdesivir/Cyanide research. I was a little shocked at first, and found it difficult to accept, but then I realized that we already knew it was deadly. We just didn’t know exactly how. We knew it caused kidney failure. Guess what, so does cyanide.

Like Mr. Baine said: “There’s a lot of doctors talking about how deadly it is, but they’re not focusing, strangely to my eyes, on what’s actually inside of it that’s causing it. And everybody needs to look under the hood and see what’s causing it.”

Subsequently to that, I began talking with @dr_SDRK on Twitter. She informed me of communications between Steve Kirsh and Victoria Yan on GS-441524. You can follow Dr SDRK’s newletter on Substack here.

Victoria Yan just happens to call herself Victoria Cyanide. Victoria is a major proponent of another Gilead compound called GS-441524. I believe GS-441524 also contains cyanide. I’ve asked her to comment, but she has not.

Miss Cyanide says they were talking in May 2020 about the virtues of GS-441524.

You can see Mr. Kirsch reference Miss Cyanide here.

I’ve been working on something more detailed on Cyanide, Victoria Yan, Florian Muller, and Steve Kirsch, but that’s taking some time. Steve Kirsch began his CETF fund with $1 million in “seed money,” then the likes of Elon Musk began funding it.

Many people are dismissive of anything said on the Stew Peter’s show, although that’s a mistake. He is a very good interviewer. It’s the person being interviewed that is bringing the information. I developed a great appreciation of his reporting after he interviewed William Teele on how a Navy vessel shot down TWA flight 800. I know that’s difficult to believe too, unless you spent a good bit of time researching it like I did. Not to go off on another tangent, but that interview finally explained it. There were hundreds of eyewitness accounts of a missile being fired, reports which the FBI obfuscated, although they dragged the bay for stinger missile tubes, before the CIA came in and shut it all down with their “exploding gas tank” narrative. See how I am on tangents?

Robert Malone went out of his way in his lawsuit against Jane Ruby and the Breggins to take some shots at Stew Peters without actually suing him.

Like Ruby, Peters and Red Voice Media have falsely accused Dr. Malone of working with the “CIA” to kill people around the world. Red Voice Media follows the format and style of InfoWars and Alex Jones, and profits from the publication of scandalous fake news about medical professionals and others, stories without factual basis designed solely to shock the audience and destroy the reputation of the target, in this case Dr. Malone.

I think it’s a bit shocking to hear the straight truth in simple and fast sentences, I agree, but that doesn’t mean he’s wrong. I respect his reporting. Peters:

It was not COVID that turned hospitals into the killing fields, the modern day progressive death camps, the ovens of 2020 and 2021, no. It was the Remdesivir death protocol which took mildly sick people and put them on a combo of Remdesivir and ventilators until they died.

But nevertheless I wanted to get some other references on Remdesivir and Cyanide if I could find them.

In the course of looking for other sources of information on Remdesivir, GS-441524, and Cyanide, I came across an article in Bloomberg.

The article was written May 4, 2020: All Eyes on Gilead. Gilead had just received a windfall grant for an EUA for Remdesivir on May 1, 2020, by the corrupt FDA. Bloomberg had some inside scoops going back into December 2019/January 2020 on Gilead.

Last New Year’s Eve, Tomas Cihlar, vice president for discovery virology at Gilead Sciences Inc., received a disturbing email from a top infectious diseases expert at the University of Virginia. The researcher had been working with Cihlar on a plan to test the Gilead drug remdesivir as a treatment for Middle East respiratory syndrome, a deadly disease caused by a coronavirus. MERS had been flaring up from time to time in Saudi Arabia and elsewhere since 2012, but this email was about something more ominous. There were cases of pneumonia suddenly emerging in Wuhan, China. Watch this one, the virologist warned. It might be a new coronavirus.

“Last New Year’s Eve” would have been December 31, 2019. The unidentified virologist in Virginia said “it might be a new coronavirus.” It just so happens this communication between Virginia and Gilead is the day after Shi Zhengli, at the Wuhan Institute of Virology, received the supposed SARS2 virus sample that came from two hospitalized patients in Wuhan. And on this December 30, 2019 day, Shi was informed that the virus was a coronavirus. Here’s that reference:

From Scientific American, June 1 2020:

The mysterious patient samples arrived at the Wuhan Institute of Virology at 7 P.M. on December 30, 2019. Moments later Shi Zhengli’s cell phone rang. It was her boss, the institute’s director. The Wuhan Center for Disease Control and Prevention had detected a novel coronavirus in two hospital patients with atypical pneumonia, and it wanted Shi’s renowned laboratory to investigate. 

These two reports are not likely to be a coincidence. They imply a level of communication between the United States and China on the nature of the alleged Wuhan virus. The virologist knew the news from China and passed it on to Tomas Cihlar, vice president for discovery virology at Gilead on December 31, 2019.

And why is that important? I’m coining a new term here: Remdesivirology. Epidemiology studies the spread of viruses. Remdesivirology studies the spread of Remdesivir homicides that have been falsely attributed to the SARS2 virus. So when I say Remdesivirology from now on that’s what I mean.

I wrote this a few months ago:

Let me delve a bit deeper into the forbidden truth of the actual origins of the alleged virus. Ian Lipkin said he was informed of a coronavirus in China on December 15, 2019, weeks before Shi Zhengli was reported to have received it. “Bloom Lab” is Jesse Bloom. He’s on Twitter. The tweet is still up, if anyone wants to talk to him about it. Apparently Lipkin also told Spike Lee the same thing about the December 15, 2019 date.

As some of you may know, Michael Callahan was in China from around October or November 2019. At some point Callahan left China and traveled to Singapore, then came back to China. George Webb has said that he believes that Callahan had the virus sequenced in Singapore. I don’t know, but it makes sense that the virus was sequences outside of China before the WIV received it.

Dr. Callahan has done extensive work with bioweapons scientists in the former Soviet Union. These scientists would give him avian flu virus samples. Callahan was in China working on a longstanding flu collaboration. Avian flu usually starts in China. Imagine that. This is from Borrell’s book, The First Shots.

The point I’m driving at, have been driving at, is that the actual SARS2 virus sequence was probably never in the Wuhan Institute of Virology. I believe it was developed at Lugar Center, and that Michael Callahan would have had access to it. Gilead did their “research” at Lugar Center. I have thought up until now that the SARS2 sequence was developed to be tested against Remdesivir at Lugar Center, but now I believe they may have been testing GS-441524 against SARS2. It’s just so, so much better, according to Yan and Kirsch.

The Director of the Wuhan Institute of Virology, Wang Yanyi, previously mentioned in the Scientific American article above, the one that talks about how they received the samples from two hospitalized patients on December 30, said that the “Wuhan Lab Leak” was a complete fabrication.

Wuhan lab head calls virus leak claims ‘pure fabrication’

Claims promoted by the Trump administration that the global pandemic originated at the Wuhan Institute of Virology in the central Chinese city are a “pure fabrication,” the institute’s director said.

Wang Yanyi was quoted by the state media on Sunday as saying the institute did not have “any knowledge before that nor had we ever met, researched or kept the virus...We didn’t even know about the existence of the virus, so how could it be leaked from our lab when we didn’t have it?”

Shi Zhengli also denied it.

"All our research results are published in English journals in the form of papers," she said. "Virus sequences are saved in the [US-run] GenBank database too. It's completely transparent. We have nothing to hide."

Now I don’t take Yanyi’s or Zhengli’s word for it. But I do know this much, the intelligence agencies of the United States are intentionally hiding the truth of whether or not that SARS2 virus sequence was ever in the Wuhan Institute of Virology. The press makes a big deal out of how the WIV database was taken offline, but they never once say that the NSA absolutely has to know exactly what was in that database. It’s their job to know. It was public website. They record stuff like that. And they won’t say. The State Department with their “fact sheets” won’t say. The reports demanded from the DNI by Congress do not request that database.

On the other hand, Lugar Center was a place where they have been intentionally releasing toxins in such an obvious and belligerent manner that you may as well call them terrorists. Listen to the locals speak of the colored smoke, the digging pipes that drain into their water.

And there’s plenty more I could add on Lugar Center. Read this and this if you’re a paid subscriber. If not, keep paying people to lie to you and then question what's wrong with the media.

OK, so back to the article by Bloomberg “All Eyes on Gilead.” What happened next after December 31, 2019? They started cranking up their Remdesivir supply lines, that’s what.

Nobody (a lie) knew at that point whether it would become a pandemic, but Gilead started planning on the assumption it could. Within weeks, Chief Executive Officer Daniel O’Day formed a task force to study how to test remdesivir and, if it worked, mass-produce it.

Thanks to its work on Ebola, Gilead already had a small supply of remdesivir on hand. Sitting in cold storage in Switzerland and California, were enough 30-milliliter vials of the drug to treat 5,000 people, which made it possible to begin human trials in the U.S., China, and elsewhere. In a factory in Edmonton, Alb., Gilead also had 100 kilograms of the bulk powder, perhaps enough to treat 90,000 patients.

To fill enough remdesivir vials to treat millions in a pandemic, however, would require a metric ton or more of the bulk drug. Gilead didn’t have close to that—and still doesn’t. So back in January it ordered more than a dozen of the most crucial starting materials and reagents from suppliers in China, Europe, and elsewhere. Gilead also helped its contractors locate sufficient supplies of compounds needed to make those starting materials.

This stuff is difficult to manufacture, according to Bloomberg. It takes months.

Even by the exacting standards of pharmaceuticals, remdesivir is tricky to produce—the monthslong process involves 70 raw materials, reagents, and catalysts.

What is one of the materials used to create Remdesivir? You guessed it. Cyanide. Trimethylsilyl cyanide, to be exact. And yes, I’ve looked at GS-441524, and it looks pretty Cyanide-y as well. Maybe even more Cyanide-y, but I’m no chemist.

Depending on how you count, there are about 25 chemical steps in the production process. Most drugs require about half that number. Some of the steps are more delicate than others. An early one uses a reagent so flammable it will spontaneously combust if exposed to air. Another involves a poison called trimethylsilyl cyanide. “If you get it on your body you better get yourself to the hospital really quick,” says Howard University chemist Joseph Fortunak, who’s analyzed the remdesivir manufacturing process. “And you still might not survive.”

So it was a bit too difficult to produce to achieve the mass levels of homicide we have seen. They had to make some adjustments.

In mid-January, Kent got a call from Reza Oliyai, senior vice president for Gilead’s pharmaceutical operations, telling him the company would need to make large quantities of remdesivir to fight the novel coronavirus. Kent immediately started calculating how long that would take. …. Kent estimated that without improvements in the process it would take 9 to 12 months to make a batch of remdesivir from scratch. …. Kent assembled a team of 20 chemists who started working on ways to speed up the manufacturing process on both the remdesivir powder made in Edmonton and the starter chemicals made by Gilead’s contractors.

On February 12, 2020, a Chinese company announced that they were producing Remdesivir in mass, and that the production had already started.

A publicly traded Chinese drug developer, BrightGene Bio-Medical Technology Co., said today it has successfully manufactured the active pharmaceutical ingredients (APIs) of remdesivir (GS-5734), the Gilead Science antiviral candidate being tested in China human clinical trials as a treatment for the 2019-nCoV novel coronavirus.

“[BrightGene] actively responded to the national call to fight the new coronavirus (2019-nCoV) epidemic, and recently successfully developed and synthesized the technology and preparations for the drug synthesis of [remdesivir] technology,” the company stated today.

“The company successfully imitated the development and production of [remdesivir] APIs by virtue of its technical accumulation in the development of high-end APIs and special injections,” BrightGene added in its statement, issued through the Shanghai Stock Exchange. “The company has produced [remdesivir] bulk drugs, and the batch production of Remdesivir preparations is in progress.”

So that’s a bit of an update on the Remdesivirology. I just wanted to share the information on the winter 2019/2020 period, because I think it supports my research. And if I ever find something that contradicts it, I’ll share that too. Awhile back I wrote about the missing Remdesivir Hepatitis trials. Well, turns out it was probably, you guessed it, GS-441524 and Hepatitis. Tomas Cihlar, Vice President of Virology at Gilead, said that “Remdesivir’s roots go back more than a decade, when its precursor was designed by Gilead medicinal chemists as a potential treatment for hepatitis C.” Fauci, Gilead, the CDC and the usual set of suspects have long been conducting their hepatitis research in Georgia. I wrote about it in the Lugar Center articles.

I only want the truth, well in addition to prosecuting the guilty.

My operating theory is that Michael Callahan took a SARS2 virus from Lugar Center to China, where he administered it to patients in hospitals in Wuhan. The virus was subsequently sequenced and uploaded to a database. They began administering Remdesivir to kill the patients, which they blamed on the virus. Later, a “vaccine” was created using the very worst part of the virus, the “spike protein” insert, and probably other parts of a virus, which people stupidly injected into their arms all over the world, which recombined into a complete virus. And then the “virus” spread around the world - in needles.

So that gets you up to date on my theory.

Charles Wright